The paper proposes a new framework called ensemble-conditioned guidance that reframes molecular design as an optimisation over both the modes and properties of a molecule’s conformational ensemble. It allows 3D generative models to be conditioned simultaneously on multiple axes—such as shapes, pharmacophore profiles, or protein pockets—by adaptively combining vector fields from each condition. The authors introduce adaptive symmetry learning for composable conditions across reference frames, extend the framework to support flexible-size generation, and demonstrate its effectiveness on new benchmarks and practical drug‑discovery tasks, showing improved outcomes when conditioning on additional states compared to single‑state approaches.
By Ross Irwin, Alessandro Tibo, Jon Paul Janet, Simon Olsson
arXiv:2606. 07239v1 Announce Type: new Abstract: The success of generative molecular design hinges on a model's steerability toward high-reward samples.
By Malte Franke, Stefan P. Schmid, Zarko Ivkovic, Kjell Jorner, Andreas Krause
arXiv:2607. 11978v1 Announce Type: cross Abstract: Precision molecular design aims to discover personalized drug candidates through joint control of multiple conditions, such as biological relevance and molecular design strategies.
By Hang Yuan, Chen Li, Wenjun Ma, Tadahiko Murata, Yuncheng Jiang
arXiv:2505. 08774v2 Announce Type: replace-cross Abstract: Designing molecules that are both property-optimal and readily synthesizable is a central challenge in drug discovery.
By Jeff Guo, V\'ictor Sabanza-Gil, Olha Semenenko, Oleksii Hrabovskyi, Mykola Protopopov, Anna Kapeliukha, Oleksandr Mosia, Sofiia Hatych, Diana Alieksieieva, Tom Nelis, Patrick Molliet, Helena Sol\'e-\`Avila, Valentas Olikauskas, Nina Aregger, Irina Morozova, Joseph Schmidt, Zlatko Jon\v{c}ev, Olga Tarkhanova, Petro Borysko, Jerome Waser, Bruno Correia, Jeremy Luterbacher, Philippe Schwaller
The paper introduces Equivariant-Free Transformer-Autoencoded Latent Flow Matching (EF‑TALFM), a two‑stage generative framework that uses a single fixed‑dimensional latent vector to produce variable‑size 3D molecules. The first stage samples the latent vector via flow matching, and the second stage employs an autoregressive Transformer decoder that determines molecule size while generating atom types, coordinates, and chemical states. EF‑TALFM outperforms prior methods on the PCQM4Mv2 benchmark, achieving higher uniqueness, novelty, and computational throughput, and its internal ranking improves the hit rate for target HOMO–LUMO gaps while maintaining novelty.
arXiv:2608.31009v1 Announce Type: new
Abstract: Structure-based drug design (SBDD) requires ligands that satisfy both 3D target affinity and 1D chemical validity. Existing controllable generation met...
By Tianyu Gao, Zhikai Su, Jiashu Li, Wenjun Gao, Zichuan Ying, Zhe Zhao, Fei Zhang, Ye Wei